• SENSEX 73,285.75
    -312.92 (--0.43%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
Back

Corporate News

GPT Healthcare to review Q2 results and interim dividend at November board meeting
27-Oct-2026, 04:28

GPT Healthcare Limited will hold a board meeting on November 5, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, along with a limited review report from its statutory auditors, and to decide on a potential interim dividend for the fiscal year 2026-27. The trading window for the company's securities will remain closed until November 7, 2026, according to the company’s “Code of Conduct for Prevention of Insider Trading.”